Showing results (221-230 of 240) with videos related to
Sort By:
Pageof 24
Plos Pathogens|September 15, 2016
Correction: Minimally Mutated HIV-1 Broadly Neutralizing Antibodies to Guide Reductionist Vaccine DesignJoseph G Jardine, Devin Sok, Jean-Philippe Julien, et al.The Journal of Clinical Investigation|March 2, 2023
Site of vulnerability on SARS-CoV-2 spike induces broadly protective antibody against antigenically distinct Omicron subvariantsSiriruk Changrob, Peter J Halfmann, Hejun Liu, et al.Cell|September 7, 2019
Antibiotics-Driven Gut Microbiome Perturbation Alters Immunity to Vaccines in HumansThomas Hagan, Mario Cortese, Nadine Rouphael, et al.Biorxiv : the Preprint Server for Biology|February 6, 2026
B Lymphocyte Protein Factories produced by Hematopoietic Stem Cell Gene EditingHarald Hartweger, Chiara Ruprecht, Kai-Hui Yao, et al.Medrxiv : the Preprint Server for Health Sciences|June 9, 2020
Proinflammatory IgG Fc structures in patients with severe COVID-19Saborni Chakraborty, Joseph Gonzalez, Karlie Edwards, et al.Research Square|September 30, 2020
Distinct B cell subsets give rise to antigen-specific antibody responses against SARS-CoV-2Christopher T Stamper, Haley L Dugan, Lei Li, et al.Nature Immunology|November 10, 2020
Proinflammatory IgG Fc structures in patients with severe COVID-19Saborni Chakraborty, Joseph Gonzalez, Karlie Edwards, et al.Science (New York, N.Y.)|April 16, 2026
B lymphocyte protein factories produced by hematopoietic stem cell gene editingHarald Hartweger, Chiara Ruprecht, Kai-Hui Yao, et al.The Journal of Experimental Medicine|January 12, 2011
Broadly cross-reactive antibodies dominate the human B cell response against 2009 pandemic H1N1 influenza virus infectionJens Wrammert, Dimitrios Koutsonanos, Gui-Mei Li, et al.Immunity|October 23, 2020
Polyreactive Broadly Neutralizing B cells Are Selected to Provide Defense against Pandemic Threat Influenza VirusesJenna J Guthmiller, Linda Yu-Ling Lan, Monica L Fernández-Quintero, et al.Pageof 24